Condition 2 for Cognitive Changes

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Cognitive Changes
N-back - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will help to determine how different types of working memory training programs can be tailored to optimize outcomes in older adults.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 9 Secondary · Reporting Duration: Day 25, Day 47, Day 79

Day 24
Training Experience Difficulty Subscale I
Training Experience Enjoyment Subscale I
Training Experience Interface Subscale I
Training Experience Subjective Progress Subscale I
Day 77
Change in Everyday Memory Questionnaire Revised
Day 78
Change in Inhibitory Control Composite Score
Change in N-level
Day 79
Change in Corsi span
Day 46
Training Experience Difficulty Subscale II
Training Experience Enjoyment Subscale II
Training Experience Interface Subscale II
Training Experience Subjective Progress Subscale II
Day 77
Change in General Cognitive Ability Composite Score
Day 79
Exit Survey

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Condition 2
1 of 2
Condition 1
1 of 2
Active Control

240 Total Participants · 2 Treatment Groups

Primary Treatment: Condition 2 · No Placebo Group · N/A

Condition 2ActiveComparator Group · 3 Interventions: N-back, Multisensory, Span · Intervention Types: Behavioral, Behavioral, Behavioral
Condition 1ActiveComparator Group · 3 Interventions: N-back, Multisensory, Span · Intervention Types: Behavioral, Behavioral, Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: day 25, day 47, day 79

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,380 Previous Clinical Trials
3,446,516 Total Patients Enrolled
12 Trials studying Cognitive Changes
2,222 Patients Enrolled for Cognitive Changes
University of California, IrvineLead Sponsor
496 Previous Clinical Trials
1,878,073 Total Patients Enrolled
3 Trials studying Cognitive Changes
576 Patients Enrolled for Cognitive Changes
University of California, RiversideOTHER
21 Previous Clinical Trials
6,454 Total Patients Enrolled
1 Trials studying Cognitive Changes
287 Patients Enrolled for Cognitive Changes
Aaron R Seitz, PhdPrincipal InvestigatorUniversity of California, Riverside
Susanne M Jaeggi, PhdPrincipal InvestigatorUniversity of California, Irvine

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are able to give consent to participate.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 5th, 2021

Last Reviewed: October 3rd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References